{"count": 11, "results": [{"_id": "35946894", "pmid": 35946894, "pmcid": "PMC9533070", "title": "The Effect of Metformin on Ethanol- and Indomethacin-Induced Gastric Ulcers in Rats", "journal": "Turk J Gastroenterol", "authors": ["İpek BE", "Yüksel M", "Cumbul A", "Ercan F", "Cabadak H", "Aydın B", "Alican İ"], "date": "2022-09-01T00:00:00Z", "doi": "10.5152/tjg.2022.21195", "meta_date_publication": "2022 Sep", "meta_volume": "33", "meta_issue": "9", "meta_pages": "767-776", "score": 50254.203, "text_hl": "This high dose was chosen to produce severe @<m>DISEASE_Stomach_Diseases</m> @DISEASE_MESH:D013272 @@@gastric lesions@@@, aiming to more clearly demonstrate the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@'s potential effect. ", "citations": {"NLM": "İpek BE, Yüksel M, Cumbul A, Ercan F, Cabadak H, Aydın B, Alican İ. The Effect of Metformin on Ethanol- and Indomethacin-Induced Gastric Ulcers in Rats Turk J Gastroenterol. 2022 Sep;33(9):767-776. PMID: 35946894", "BibTeX": "@article{35946894, title={The Effect of Metformin on Ethanol- and Indomethacin-Induced Gastric Ulcers in Rats}, author={İpek BE and Yüksel M and Cumbul A and Ercan F and Cabadak H and Aydın B and Alican İ}, journal={Turk J Gastroenterol}, volume={33}, number={9}, pages={767-776}}"}}, {"_id": "33345855", "pmid": 33345855, "title": "The effect of metformin on indomethacin-induced gastric ulcer: Involvement of nitric oxide/Rho kinase pathway.", "journal": "Eur J Pharmacol", "authors": ["AbdelAziz EY", "Tadros MG", "Menze ET"], "date": "2021-02-05T00:00:00Z", "doi": "10.1016/j.ejphar.2020.173812", "meta_date_publication": "2021 Feb 5", "meta_volume": "892", "meta_issue": "", "meta_pages": "173812", "score": 50248.195, "text_hl": "@CHEMICAL_Omeprazole @CHEMICAL_MESH:D009853 @@@Omeprazole@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ were found to decrease @<m>DISEASE_Stomach_Diseases</m> @DISEASE_MESH:D013272 @@@stomach@@@ acidity and @DISEASE_Ulcer @DISEASE_MESH:D014456 @@@ulcer@@@ index, restored the histological features and increased @GENE_SLC13A2 @GENE_65202 @@@mucin@@@ levels. ", "citations": {"NLM": "AbdelAziz EY, Tadros MG, Menze ET. The effect of metformin on indomethacin-induced gastric ulcer: Involvement of nitric oxide/Rho kinase pathway. Eur J Pharmacol. 2021 Feb 5;892():173812. PMID: 33345855", "BibTeX": "@article{33345855, title={The effect of metformin on indomethacin-induced gastric ulcer: Involvement of nitric oxide/Rho kinase pathway.}, author={AbdelAziz EY and Tadros MG and Menze ET}, journal={Eur J Pharmacol}, volume={892}, pages={173812}}"}}, {"_id": "35731346", "pmid": 35731346, "title": "Helicobacter pylori-mediated gastric pathogenesis is attenuated by treatment of 2-deoxyglucose and metformin.", "journal": "J Microbiol", "authors": ["Su H", "Bak EJ", "Kim A", "Tissera K", "Cha JH", "Jang S"], "date": "2022-08-01T00:00:00Z", "doi": "10.1007/s12275-022-2130-z", "meta_date_publication": "2022 Aug", "meta_volume": "60", "meta_issue": "8", "meta_pages": "849-858", "score": 50246.973, "text_hl": "Our findings demonstrate that the progression of gastric pathogenesis induced by @DISEASE_Helicobacter_Infections @DISEASE_MESH:D016481 @@@H. pylori infection@@@ can be attenuated by the short-term individual or combinational treatment of @CHEMICAL_Deoxyglucose @CHEMICAL_MESH:D003847 @@@2DG@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Met@@@, implying that @CHEMICAL_Deoxyglucose @CHEMICAL_MESH:D003847 @@@2DG@@@ or @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Met@@@ could be considered as a treatment option for @<m>DISEASE_Stomach_Diseases</m> @DISEASE_MESH:D013272 @@@gastric diseases@@@ in the early stages of @DISEASE_Infections @DISEASE_MESH:D007239 @@@infection@@@.", "citations": {"NLM": "Su H, Bak EJ, Kim A, Tissera K, Cha JH, Jang S. Helicobacter pylori-mediated gastric pathogenesis is attenuated by treatment of 2-deoxyglucose and metformin. J Microbiol. 2022 Aug;60(8):849-858. PMID: 35731346", "BibTeX": "@article{35731346, title={Helicobacter pylori-mediated gastric pathogenesis is attenuated by treatment of 2-deoxyglucose and metformin.}, author={Su H and Bak EJ and Kim A and Tissera K and Cha JH and Jang S}, journal={J Microbiol}, volume={60}, number={8}, pages={849-858}}"}}, {"_id": "39696781", "pmid": 39696781, "title": "Corticosteroids plus metformin versus corticosteroids as front-line treatment for patients with newly diagnosed ITP and pre-existing type 2 diabetes mellitus: A multicentre propensity score-matched study.", "journal": "Br J Haematol", "authors": ["Hou XR", "Yan ZY", "Liu S", "Gao N", "Chen J", "Wang YW", "Wang L", "Li Z", "Wang XR", "Dong QF", "Wang QY", "Sun L", "Wang YM", "Ma J", "Zhao YJ", "Xu ZL", "Cao CC", "Peng J", "Hou M", "Liu XG"], "date": "2024-12-18T00:00:00Z", "doi": "10.1111/bjh.19940", "meta_date_publication": "2024 Dec 18", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50245.496, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ inclusion was associated with a higher incidence of @<m>DISEASE_Stomach_Diseases</m> @DISEASE_MESH:D013272 @@@stomach upset@@@, which were generally tolerable. ", "citations": {"NLM": "Hou XR, Yan ZY, Liu S, Gao N, Chen J, Wang YW, Wang L, Li Z, Wang XR, Dong QF, Wang QY, Sun L, Wang YM, Ma J, Zhao YJ, Xu ZL, Cao CC, Peng J, Hou M, Liu XG. Corticosteroids plus metformin versus corticosteroids as front-line treatment for patients with newly diagnosed ITP and pre-existing type 2 diabetes mellitus: A multicentre propensity score-matched study. Br J Haematol. 2024 Dec 18;():. PMID: 39696781", "BibTeX": "@article{39696781, title={Corticosteroids plus metformin versus corticosteroids as front-line treatment for patients with newly diagnosed ITP and pre-existing type 2 diabetes mellitus: A multicentre propensity score-matched study.}, author={Hou XR and Yan ZY and Liu S and Gao N and Chen J and Wang YW and Wang L and Li Z and Wang XR and Dong QF and Wang QY and Sun L and Wang YM and Ma J and Zhao YJ and Xu ZL and Cao CC and Peng J and Hou M and Liu XG}, journal={Br J Haematol}}"}}, {"_id": "37153436", "pmid": 37153436, "pmcid": "PMC10160701", "title": "Combinational administration of mesenchymal stem cell-derived exosomes and metformin reduces inflammatory responses in an in vitro model of insulin resistance in HepG2 cells", "journal": "Heliyon", "authors": ["Malekpour K", "Hazrati A", "Soudi S", "Roshangar L", "Pourfathollah AA", "Ahmadi M"], "date": "2023-04-14T00:00:00Z", "doi": "10.1016/j.heliyon.2023.e15489", "meta_date_publication": "2023 May", "meta_volume": "9", "meta_issue": "5", "meta_pages": "e15489", "score": 50242.242, "text_hl": "The use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ has side effects, including a @DISEASE_Taste_Disorders @DISEASE_MESH:D013651 @@@metallic taste in the mouth@@@, @DISEASE_Vomiting @DISEASE_MESH:D014839 @@@vomiting@@@, @DISEASE_Nausea @DISEASE_MESH:D009325 @@@nausea@@@, @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhea@@@, and @<m>DISEASE_Stomach_Diseases</m> @DISEASE_MESH:D013272 @@@upset stomach@@@. ", "citations": {"NLM": "Malekpour K, Hazrati A, Soudi S, Roshangar L, Pourfathollah AA, Ahmadi M. Combinational administration of mesenchymal stem cell-derived exosomes and metformin reduces inflammatory responses in an in vitro model of insulin resistance in HepG2 cells Heliyon. 2023 May;9(5):e15489. PMID: 37153436", "BibTeX": "@article{37153436, title={Combinational administration of mesenchymal stem cell-derived exosomes and metformin reduces inflammatory responses in an in vitro model of insulin resistance in HepG2 cells}, author={Malekpour K and Hazrati A and Soudi S and Roshangar L and Pourfathollah AA and Ahmadi M}, journal={Heliyon}, volume={9}, number={5}, pages={e15489}}"}}, {"_id": "33095998", "pmid": 33095998, "title": "The intervention of tert-butylhydroquinone protects ethanol-induced gastric ulcer in type II diabetic rats: the role of Nrf2 pathway.", "journal": "Can J Physiol Pharmacol", "authors": ["Rahman Z", "Dwivedi DK", "Jena GB"], "date": "2021-05-01T00:00:00Z", "doi": "10.1139/cjpp-2020-0173", "meta_date_publication": "2021 May", "meta_volume": "99", "meta_issue": "5", "meta_pages": "522-535", "score": 50237.023, "text_hl": "In @CHEMICAL_Ethanol @CHEMICAL_MESH:D000431 @@@ethanol@@@-exposed @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_10116 @@@rats@@@, pretreatment with @CHEMICAL_2_tert_butylhydroquinone @CHEMICAL_MESH:C018855 @@@tBHQ@@@, @CHEMICAL_Omeprazole @CHEMICAL_MESH:D009853 @@@omeprazole@@@, and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ reduced @<m>DISEASE_Stomach_Diseases</m> @DISEASE_MESH:D013272 @@@gastric mucosal lesion@@@, @DISEASE_Ulcer @DISEASE_MESH:D014456 @@@ulcer@@@ index, histological alterations, @CHEMICAL_Malondialdehyde @CHEMICAL_MESH:D008315 @@@malondialdehyde@@@ level, and apoptosis. ", "citations": {"NLM": "Rahman Z, Dwivedi DK, Jena GB. The intervention of tert-butylhydroquinone protects ethanol-induced gastric ulcer in type II diabetic rats: the role of Nrf2 pathway. Can J Physiol Pharmacol. 2021 May;99(5):522-535. PMID: 33095998", "BibTeX": "@article{33095998, title={The intervention of tert-butylhydroquinone protects ethanol-induced gastric ulcer in type II diabetic rats: the role of Nrf2 pathway.}, author={Rahman Z and Dwivedi DK and Jena GB}, journal={Can J Physiol Pharmacol}, volume={99}, number={5}, pages={522-535}}"}}, {"_id": "28822889", "pmid": 28822889, "title": "Metformin targets gastric cancer stem cells.", "journal": "Eur J Cancer", "authors": ["Courtois S", "Durán RV", "Giraud J", "Sifré E", "Izotte J", "Mégraud F", "Lehours P", "Varon C", "Bessède E"], "date": "2017-10-01T00:00:00Z", "doi": "10.1016/j.ejca.2017.07.020", "meta_date_publication": "2017 Oct", "meta_volume": "84", "meta_issue": "", "meta_pages": "193-201", "score": 50062.535, "text_hl": "These results suggest that the use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ could represent an efficient strategy to inhibit @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumour@@@ growth by targeting @<m>DISEASE_Stomach_Diseases</m> @DISEASE_MESH:D013272 @@@gastric@@@ CSCs.", "citations": {"NLM": "Courtois S, Durán RV, Giraud J, Sifré E, Izotte J, Mégraud F, Lehours P, Varon C, Bessède E. Metformin targets gastric cancer stem cells. Eur J Cancer. 2017 Oct;84():193-201. PMID: 28822889", "BibTeX": "@article{28822889, title={Metformin targets gastric cancer stem cells.}, author={Courtois S and Durán RV and Giraud J and Sifré E and Izotte J and Mégraud F and Lehours P and Varon C and Bessède E}, journal={Eur J Cancer}, volume={84}, pages={193-201}}"}}, {"_id": "31132357", "pmid": 31132357, "title": "Alendronate-induced gastric damage in normoglycemic and hyperglycemic rats is reversed by metformin.", "journal": "Eur J Pharmacol", "authors": ["Nolêto IRSG", "Iles B", "Alencar MS", "Lopes ALF", "Oliveira AP", "Pacheco G", "Sousa FBM", "Araújo AR", "Alves EHP", "Vasconcelos DFP", "Leal LKAM", "Araújo AJ", "Filho JDBM", "Medeiros JVR"], "date": "2019-08-05T00:00:00Z", "doi": "10.1016/j.ejphar.2019.172410", "meta_date_publication": "2019 Aug 5", "meta_volume": "856", "meta_issue": "", "meta_pages": "172410", "score": 50060.633, "text_hl": "@CHEMICAL_Alendronate @CHEMICAL_MESH:D019386 @@@Alendronate@@@-induced @<m>DISEASE_Stomach_Diseases</m> @DISEASE_MESH:D013272 @@@gastric damage@@@ in normoglycemic and @DISEASE_Hyperglycemic_Hyperosmolar_Nonketotic_Coma @DISEASE_MESH:D006944 @@@hyperglycemic@@@ @SPECIES_10116 @@@rats@@@ is reversed by @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@.", "citations": {"NLM": "Nolêto IRSG, Iles B, Alencar MS, Lopes ALF, Oliveira AP, Pacheco G, Sousa FBM, Araújo AR, Alves EHP, Vasconcelos DFP, Leal LKAM, Araújo AJ, Filho JDBM, Medeiros JVR. Alendronate-induced gastric damage in normoglycemic and hyperglycemic rats is reversed by metformin. Eur J Pharmacol. 2019 Aug 5;856():172410. PMID: 31132357", "BibTeX": "@article{31132357, title={Alendronate-induced gastric damage in normoglycemic and hyperglycemic rats is reversed by metformin.}, author={Nolêto IRSG and Iles B and Alencar MS and Lopes ALF and Oliveira AP and Pacheco G and Sousa FBM and Araújo AR and Alves EHP and Vasconcelos DFP and Leal LKAM and Araújo AJ and Filho JDBM and Medeiros JVR}, journal={Eur J Pharmacol}, volume={856}, pages={172410}}"}}, {"_id": "28407669", "pmid": 28407669, "title": "Metformin Inhibits N-Methyl-N-Nitrosourea Induced Gastric Tumorigenesis in db/db Mice.", "journal": "Exp Clin Endocrinol Diabetes", "authors": ["Zhuang S", "Jian Y", "Sun Y"], "date": "2017-06-01T00:00:00Z", "doi": "10.1055/s-0043-100118", "meta_date_publication": "2017 Jun", "meta_volume": "125", "meta_issue": "6", "meta_pages": "392-399", "score": 50051.434, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ significantly decreased incidence of @CHEMICAL_Methylnitrosourea @CHEMICAL_MESH:D008770 @@@MNU@@@-induced @<m>DISEASE_Stomach_Diseases</m> @DISEASE_MESH:D013272 @@@gastric dysplasia@@@ and @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@ in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ db/db @SPECIES_10090 @@@mice@@@. ", "citations": {"NLM": "Zhuang S, Jian Y, Sun Y. Metformin Inhibits N-Methyl-N-Nitrosourea Induced Gastric Tumorigenesis in db/db Mice. Exp Clin Endocrinol Diabetes. 2017 Jun;125(6):392-399. PMID: 28407669", "BibTeX": "@article{28407669, title={Metformin Inhibits N-Methyl-N-Nitrosourea Induced Gastric Tumorigenesis in db/db Mice.}, author={Zhuang S and Jian Y and Sun Y}, journal={Exp Clin Endocrinol Diabetes}, volume={125}, number={6}, pages={392-399}}"}}, {"_id": "23351604", "pmid": 23351604, "pmcid": "PMC3556082", "title": "Metformin loaded non-ionic surfactant vesicles: optimization of formulation, effect of process variables and characterization", "journal": "Daru", "authors": ["Sankhyan A", "Pawar PK"], "date": "2013-01-11T00:00:00Z", "doi": "10.1186/2008-2231-21-7", "meta_date_publication": "2013 Jan 11", "meta_volume": "21", "meta_issue": "1", "meta_pages": "7", "score": 50049.51, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ an oral hypoglycemic has been widely used as a fist line of treatment of @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@Type II Diabetes@@@ but in a very high dose 2-3 times a day and moreover suffers from a number of side effects like @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@lactic acidosis@@@, @<m>DISEASE_Stomach_Diseases</m> @DISEASE_MESH:D013272 @@@gastric discomfort@@@, @DISEASE_Chest_Pain @DISEASE_MESH:D002637 @@@chest pain@@@, @DISEASE_Drug_Hypersensitivity @DISEASE_MESH:D004342 @@@allergic reactions@@@ being some of them. ", "citations": {"NLM": "Sankhyan A, Pawar PK. Metformin loaded non-ionic surfactant vesicles: optimization of formulation, effect of process variables and characterization Daru. 2013 Jan 11;21(1):7. PMID: 23351604", "BibTeX": "@article{23351604, title={Metformin loaded non-ionic surfactant vesicles: optimization of formulation, effect of process variables and characterization}, author={Sankhyan A and Pawar PK}, journal={Daru}, volume={21}, number={1}, pages={7}}"}}]}